Please assess the completion status of the following clinical trial:

Trial Title: Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* New Deplin® Start~* Only for patients with depression who have been prescribed brand name Deplin® to help metabolic management of depression.~* Clinically depressed patients who have been prescribed Deplin® in combination with an antidepressant.~* At the start of antidepressant therapy~* As augmentation to antidepressant therapy~Exclusion Criteria:~* Patients who do not meet DSM IV criteria for major depression~* If participant indicates that he or she did not get a prescription for Deplin®, he/she will not be able to complete the survey(s).~* For follow-up surveys, if the participant indicates that he/she has not been taking Deplin®, he/she will not be able to complete the survey(s).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Deplin® (Type: None): Subjects with depression who have been prescribed Deplin® daily.

Based on this trial design, predict the completion outcome and termination type (if applicable).